Progress toward an integrated understanding of Parkinson’s disease

@inproceedings{Rousseaux2017ProgressTA,
  title={Progress toward an integrated understanding of Parkinson’s disease},
  author={Maxime W. C. Rousseaux and Joshua M Shulman and Joseph Jankovic},
  booktitle={F1000Research},
  year={2017}
}
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, affecting over 10 million individuals worldwide. While numerous effective symptomatic treatments are currently available, no curative or disease-modifying therapies exist. An integrated, comprehensive understanding of PD pathogenic mechanisms will likely address this unmet clinical need. Here, we highlight recent progress in PD research with an emphasis on promising translational findings… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
4 Citations
82 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 82 references

Results from a phase 1 b multiple ascendingdose study of PRX 002 , an antialpha - synuclein monoclonal antibody , in patients with Parkinson ’ s disease

  • J Jankovic, I Godman, B Safirstein
  • Neurodegener Dis .
  • 2017

Similar Papers

Loading similar papers…